A press report revealed that there are differences between Germany and the United States of America about a German company in the province of Tubingen in southern Germany, in which work is being made to reach a vaccine against the emerging corona virus (Covid 19).

According to a report by the German weekly "Welt am Sonntag" published in its Sunday edition, according to government departments in the capital, Berlin, that US President Donald Trump is trying to attract German scientists to his country with high financial transfers or to guarantee the vaccine exclusively for his country.

The newspaper pointed out that the American president offers the German company a large sum to ensure that it works exclusively for his country, adding that he is doing all this in order to obtain the vaccine for the United States of America only.

In response to a question from the German News Agency (dpa), the Federal Ministry of Health in Germany referred to the statements made by a ministry spokesman before to the newspaper "Welt am Sonntag", in which he said: "The German government is very interested in developing Vaccines and effective materials against the emerging coronavirus in Germany and Europe, and in this regard the government is communicating extensively with the CureFac company, which is based in Tübingen.

The newspaper added that Germany is trying to supply the company with money.

According to the newspaper report, the company is working with the German State Institute for Vaccines and Biomedical Medicines to produce a vaccine against the emerging corona virus.